ARTICLE | Company News
GSK exercises option for Galapagos compounds
February 22, 2012 1:38 AM UTC
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exercised an option to license exclusive, worldwide rights from Galapagos N.V. (Euronext:GLPG; Pink:GLPYY) to develop and commercialize GLPG0778, a small molecu...